MODULATEURS DE TRANSPORT NUCLÉAIRE ET LEURS UTILISATIONS

• 收藏
• 分享

专利权人:

Inc.;Karyopharm Therapeutics

发明人:

申请号：

EP12748083.8

公开号：

EP2736883B1

申请日:

2012.07.26

申请国别(地区):

EP

年份:

2019

代理人:

摘要：

or a pharmaceutically acceptable salt thereof, wherein the variables are as defined and described herein. The invention also includes the synthesis and use of a compound of structural formula I, or a pharmaceutically acceptable salt or composition thereof, e.g., in the treatment, modulation and/or prevention of physiological conditions associated with CRM1 activity.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/